IMCC · IM Cannabis Corp.
$0.11
0.00 (-1.14%)
At close · Aug 21
Market Cap
$1.84M
Shares
16.30M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.11
Open$0.12
Day$0.11–0.12
52W close$0.10–2.44
Avg vol 30d4.6M
Short int474K · 2.9% float · 1.0d
Short vol43%
DataJul 2024–Aug 2026
Raw chart and full-history price indicators begin at the captured split on Jul 12, 2024; bars on opposite sides are not compared.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 15.1 · calm
Equity put/call 0.51
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−84%
below
Price vs 50-day avg
−23%
below
RSI (14)
38
neutral
MACD trend
Positive
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−7%
trailing
6-month return
−84%
trailing
YTD return
−92%
this year
Relative strength
−96%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+40% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
2.91% of float · ▲ +121.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
14 holders — mid 3-yr range
Squeeze score
50
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
108%
annualized · 1-yr
Max drawdown
−96%
past year
ATR
12.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−84%
Bearish
Price vs 50-day avg
−23%
Bearish
RSI (14)
38
Neutral
MACD trend
Positive
Bullish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+40% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
2.91% of float · ▲ +121.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
14 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $0
Now $0 · 0%
Range high $2
vs 200-day avg -84%
vs 50-day avg -23%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IMCC
this stock
IM Cannabis Corp.
|
$1.84M | -91.9% | — | — | 2.9% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$66.37B | — | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$58.06B | +16.6% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$49.91B | +3.3% | — | — | 0.0% |
|
HLN
Haleon plc
|
$43.98B | -1.1% | — | — | 0.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Performance
Raw-price comparisons begin at the captured split on Jul 12, 2024; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IMCC | -7.5% | -6.8% | -84.4% | -2.8% | -91.9% |
| SPY | -1.4% | +3.6% | +11.6% | +2.5% | +12.3% |
| vs SPY | -6.2% | -10.4% | -95.9% | -5.3% | -104.2% |
Key facts
CIK
1792030
CUSIP
44969Q406
13F (30d)
13 filings
13 filers
Visit website
Investor relations